The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed for diabetes that are now being used to help people lose significant ...

Explore Allurion Technologies' Q2 2025 strategic shift focusing on combination therapies for obesity management, R&D innovation, and long-term ...